Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz in high-grade serous ovarian cancer

Matthews, B Wong-Brown, M Liu, D Yee, C Dickson, K-A Schneider, J Islam, S Head, R Martin, JH Ford, CE Marsh, DJ Bowden, NA

Permalink

Open Access

Copyright Clearance Process

This item is open access.

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Matthews, B
dc.contributor.author	Wong-Brown, M
dc.contributor.author	Liu, D
dc.contributor.author	Yee, C
dc.contributor.author	Dickson, K-A
dc.contributor.author	Schneider, J
dc.contributor.author	Islam, S
dc.contributor.author	Head, R
dc.contributor.author	Martin, JH
dc.contributor.author	Ford, CE
dc.contributor.author	Marsh, DJ
dc.contributor.author	Bowden, NA
dc.date.accessioned	2024-12-20T04:23:57Z
dc.date.available	2024-12-20T04:23:57Z
dc.date.issued	2024-11
dc.identifier.citation	Molecular Therapy Oncology, 2024, pp. 200911
dc.identifier.issn	2950-3299
dc.identifier.uri	http://hdl.handle.net/10453/182730
dc.language	en
dc.publisher	Elsevier
dc.relation	Medical Research Future FundAPP1199620
dc.relation.ispartof	Molecular Therapy Oncology
dc.relation.isbasedon	10.1016/j.omton.2024.200911
dc.rights	info:eu-repo/semantics/openAccess
dc.title	Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz in high-grade serous ovarian cancer
dc.type	Journal Article
pubs.organisational-group	University of Technology Sydney
pubs.organisational-group	University of Technology Sydney/Faculty of Science
pubs.organisational-group	University of Technology Sydney/Faculty of Science/School of Life Sciences
pubs.organisational-group	University of Technology Sydney/UTS Groups
pubs.organisational-group	University of Technology Sydney/UTS Groups/Centre for Health Technologies (CHT)
utslib.copyright.status	open_access	*
dc.date.updated	2024-12-20T04:23:56Z
pubs.publication-status	Published

Please use this identifier to cite or link to this item: